Showing results (141-150 of 646) with videos related to

Sort By:
Pageof 65
Hemasphere|June 17, 2026
CEBP and ZEB2 alterations define three distinct subtypes of B-cell acute lymphoblastic leukemiaRathana Kim, Marie Passet, Hugo Bergugnat, et al.
Hemasphere|July 8, 2026
Inflammatory signatures in the spectrum of myeloid diseasesAlice Ibbotson, Simon Crouch, Jacqueline Ferrari, et al.
Hemasphere|June 22, 2026
Minimally invasive characterization of peripheral blood measurable residual disease in multiple myeloma using high-sensitivity detection of ctDNA by next-generation sequencingNatalia Buenache, Marta Lasa, Andrés Arroyo, et al.
Hemasphere|July 15, 2026
Risk of thrombosis and bleeding following CAR T-cell therapy: Insights from the Dutch "Follow that CAR!" registryAmica K Ko, Pim G N J Mutsaers, Lukas M van Kleij, et al.
Hemasphere|August 4, 2026
Passenger variants as pan-clonal markers of pediatric AML: Implications for molecular MRDRuth Shiloh, Dana Dayan, Ifat Geron, et al.
Hemasphere|August 5, 2026
First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphomaUmberto Vitolo, Lorenzo Falchi, Per-Ola Andersson, et al.
Hemasphere|August 12, 2026
Venetoclax plus azacitidine, low-dose cytarabine, aclarubicin, and G-CSF (VA-CAG regimen) for newly diagnosed young patients with acute myeloid leukemia: A prospective, multicenter, single-arm Phase II clinical trialXiaoping Li, Qiurong Zhang, Xiaoyan Li, et al.
Hemasphere|May 10, 2021
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making AlgorithmDonatella Baronciani, Maddalena Casale, Lucia De Franceschi, et al.
Hemasphere|April 29, 2021
Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic LeukemiaTom A Mulder, Lucía Peña-Pérez, Anna Berglöf, et al.
Hemasphere|August 5, 2022
Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA TherapyIoannis Ntanasis-Stathopoulos, Vangelis Karalis, Maria Gavriatopoulou, et al.
Pageof 65